Each mL of CLEOCIN PHOSPHATE Sterile Solution contains clindamycin phosphate equivalent to 150 mg clindamycin, 0.5 mg disodium edetate, 9.45 mg benzyl alcohol added as preservative. When necessary, pH is adjusted with sodium hydroxide and/or hydrochloric acid. CLEOCIN PHOSPHATE is available in the following packages:
| 25-2 mL vials | NDC 0009-0870-26 | |
| 25-4 mL vials | NDC 0009-0775-26 | |
| 25-6 mL vials | NDC 0009-0902-18 | |
| 5-60 mL Pharmacy Bulk Package | NDC 0009-0728-09 |
CLEOCIN PHOSPHATE is supplied in ADD-Vantage vials as follows:
| NDC | Vial Size | Total Clindamycin Phosphate/vial |
|---|---|---|
| 0009-6582-01 | 25-2 mL Vials | 300 mg |
| 0009-3124-03 | 25-4 mL Vials | 600 mg |
| 0009-3447-03 | 25-6 mL Vials | 900 mg |
CLEOCIN PHOSPHATE IV Solution in GALAXY plastic containers is a sterile solution of clindamycin phosphate with 5% dextrose. The single dose GALAXY plastic containers are available as follows:
| 24-300 mg/50 mL containers | NDC 0009-3381-02 |
| 24-600 mg/50 mL containers | NDC 0009-3375-02 |
| 24-900 mg/50 mL containers | NDC 0009-3382-02 |
Each mL of CLEOCIN PHOSPHATE Sterile Solution contains clindamycin phosphate equivalent to 150 mg clindamycin, 0.5 mg disodium edetate, 9.45 mg benzyl alcohol added as preservative. When necessary, pH is adjusted with sodium hydroxide and/or hydrochloric acid. CLEOCIN PHOSPHATE is available in the following packages:
| 25-2 mL vials | NDC 0009-0870-26 | |
| 25-4 mL vials | NDC 0009-0775-26 | |
| 25-6 mL vials | NDC 0009-0902-18 | |
| 5-60 mL Pharmacy Bulk Package | NDC 0009-0728-09 |
CLEOCIN PHOSPHATE is supplied in ADD-Vantage vials as follows:
| NDC | Vial Size | Total Clindamycin Phosphate/vial |
|---|---|---|
| 0009-6582-01 | 25-2 mL Vials | 300 mg |
| 0009-3124-03 | 25-4 mL Vials | 600 mg |
| 0009-3447-03 | 25-6 mL Vials | 900 mg |
CLEOCIN PHOSPHATE IV Solution in GALAXY plastic containers is a sterile solution of clindamycin phosphate with 5% dextrose. The single dose GALAXY plastic containers are available as follows:
| 24-300 mg/50 mL containers | NDC 0009-3381-02 |
| 24-600 mg/50 mL containers | NDC 0009-3375-02 |
| 24-900 mg/50 mL containers | NDC 0009-3382-02 |
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.